Cargando…
Inhibitors of the integrase–transportin-SR2 interaction block HIV nuclear import
BACKGROUND: Combination antiretroviral therapy efficiently suppresses HIV replication in infected patients, transforming HIV/AIDS into a chronic disease. Viral resistance does develop however, especially under suboptimal treatment conditions such as poor adherence. As a consequence, continued explor...
Autores principales: | Demeulemeester, Jonas, Blokken, Jolien, De Houwer, Stéphanie, Dirix, Lieve, Klaassen, Hugo, Marchand, Arnaud, Chaltin, Patrick, Christ, Frauke, Debyser, Zeger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767004/ https://www.ncbi.nlm.nih.gov/pubmed/29329553 http://dx.doi.org/10.1186/s12977-018-0389-2 |
Ejemplares similares
-
Interplay between HIV Entry and Transportin-SR2 Dependency
por: Thys, Wannes, et al.
Publicado: (2011) -
Dynamic Oligomerization of Integrase Orchestrates HIV Nuclear Entry
por: Borrenberghs, Doortje, et al.
Publicado: (2016) -
Role of Transportin-SR2 in HIV-1 Nuclear Import
por: Tabasi, Maryam, et al.
Publicado: (2021) -
CRISPR/Cas9-Induced Mutagenesis Corroborates the Role of Transportin-SR2 in HIV-1 Nuclear Import
por: Janssens, Julie, et al.
Publicado: (2021) -
Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
por: Taltynov, Oliver, et al.
Publicado: (2012)